{"log_id": 5041105132410044482, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 8e-06, "average": 0.998394, "min": 0.983695}, "location": {"width": 678, "top": 220, "height": 37, "left": 209}, "words": "或安慰剂),患者在2项研究的全过程中还服用了经调整的钙和维生素D补充剂"}, {"probability": {"variance": 0.001914, "average": 0.985311, "min": 0.761416}, "location": {"width": 789, "top": 266, "height": 40, "left": 247}, "words": "在SOTI研究中,经过3年的治疗,本品降低新发生的椎体骨折的相对危险性达41%(详见表"}, {"probability": {"variance": 0.000372, "average": 0.991425, "min": 0.902032}, "location": {"width": 826, "top": 312, "height": 41, "left": 209}, "words": ")。这种作用在治疗1年后就显著地表现出来。在入选时已有过多处骨折的妇女被证明获得了相似"}, {"probability": {"variance": 0.000284, "average": 0.991298, "min": 0.932242}, "location": {"width": 827, "top": 357, "height": 42, "left": 207}, "words": "的益处。而就临床椎体骨折(定义为与背痛有关的骨折和或身高至少降低1cm)而论,相对危险性"}, {"probability": {"variance": 0.005258, "average": 0.981718, "min": 0.546353}, "location": {"width": 812, "top": 404, "height": 40, "left": 206}, "words": "降低了38%。与安慰剂相比,本品同时减少了身高至少降低1cm的患者数。同样与安慰剂相比"}, {"probability": {"variance": 0.001421, "average": 0.98765, "min": 0.766708}, "location": {"width": 788, "top": 449, "height": 41, "left": 210}, "words": " QUALIOS特殊量表的生活质量评价和SF-36普通量表的一般健康预测评分显示了本品的益处"}, {"probability": {"variance": 0.002049, "average": 0.986688, "min": 0.790054}, "location": {"width": 789, "top": 495, "height": 41, "left": 244}, "words": "本品降低新发生的体骨折的危险性的疗效在 TROPOS研究中得到了证实,包括在治疗前没"}, {"probability": {"variance": 9e-06, "average": 0.996553, "min": 0.991333}, "location": {"width": 239, "top": 540, "height": 30, "left": 204}, "words": "有脆性骨折的骨质疏松患者"}, {"probability": {"variance": 0.012727, "average": 0.964513, "min": 0.493698}, "location": {"width": 431, "top": 631, "height": 35, "left": 202}, "words": "麦1:椎体骨折患者的发生率和相对危险性的降低"}, {"probability": {"variance": 0, "average": 0.999481, "min": 0.998915}, "location": {"width": 61, "top": 685, "height": 24, "left": 513}, "words": "安慰剂"}, {"probability": {"variance": 0.0042, "average": 0.975979, "min": 0.68258}, "location": {"width": 447, "top": 685, "height": 38, "left": 630}, "words": "本品与安慰剂相比的相对危险性(95%C),P值"}, {"probability": {"variance": 0, "average": 0.933126, "min": 0.933126}, "location": {"width": 50, "top": 732, "height": 20, "left": 316}, "words": " SOTI"}, {"probability": {"variance": 0.000275, "average": 0.986512, "min": 0.963123}, "location": {"width": 39, "top": 736, "height": 20, "left": 622}, "words": "N=7"}, {"probability": {"variance": 0.000403, "average": 0.988983, "min": 0.928739}, "location": {"width": 237, "top": 772, "height": 29, "left": 202}, "words": "在3年中新发生的椎体骨折"}, {"probability": {"variance": 0.015314, "average": 0.913832, "min": 0.51758}, "location": {"width": 367, "top": 780, "height": 28, "left": 516}, "words": "3.8%20941%(27-52),p=0.01"}, {"probability": {"variance": 0.004552, "average": 0.972245, "min": 0.748688}, "location": {"width": 257, "top": 817, "height": 30, "left": 201}, "words": "在第1年中新发生的椎体骨折"}, {"probability": {"variance": 0.001191, "average": 0.957304, "min": 0.900273}, "location": {"width": 42, "top": 826, "height": 20, "left": 516}, "words": "11.8"}, {"probability": {"variance": 0.024464, "average": 0.907348, "min": 0.42916}, "location": {"width": 152, "top": 830, "height": 25, "left": 723}, "words": "9%(26-64),p0.00"}, {"probability": {"variance": 0.002857, "average": 0.973422, "min": 0.80386}, "location": {"width": 357, "top": 864, "height": 29, "left": 202}, "words": "在3年中新发生的临床椎体骨折1.4%"}, {"probability": {"variance": 0.028527, "average": 0.895158, "min": 0.448349}, "location": {"width": 262, "top": 872, "height": 31, "left": 623}, "words": "11.3%38%4(17-53)p<0.00"}, {"probability": {"variance": 0, "average": 0.999736, "min": 0.999736}, "location": {"width": 96, "top": 879, "height": 38, "left": 924}, "words": "国"}, {"probability": {"variance": 0, "average": 0.951583, "min": 0.951583}, "location": {"width": 71, "top": 916, "height": 19, "left": 307}, "words": " ROPOS"}, {"probability": {"variance": 0.001642, "average": 0.980723, "min": 0.874183}, "location": {"width": 132, "top": 920, "height": 22, "left": 549}, "words": "23N=1817"}, {"probability": {"variance": 0.02285, "average": 0.950862, "min": 0.44974}, "location": {"width": 238, "top": 955, "height": 31, "left": 199}, "words": "在3年中新发生的椎体骨折"}, {"probability": {"variance": 0.000235, "average": 0.988576, "min": 0.95932}, "location": {"width": 44, "top": 964, "height": 21, "left": 513}, "words": "20.0%"}, {"probability": {"variance": 0.001123, "average": 0.970044, "min": 0.921835}, "location": {"width": 46, "top": 965, "height": 21, "left": 623}, "words": "12.5%"}, {"probability": {"variance": 0.034094, "average": 0.832572, "min": 0.419773}, "location": {"width": 118, "top": 969, "height": 26, "left": 759}, "words": "2-49).0.00"}, {"probability": {"variance": 0.004366, "average": 0.600183, "min": 0.534105}, "location": {"width": 63, "top": 960, "height": 27, "left": 972}, "words": "公/"}, {"probability": {"variance": 0, "average": 0.832333, "min": 0.832333}, "location": {"width": 83, "top": 997, "height": 30, "left": 890}, "words": "市"}, {"probability": {"variance": 0, "average": 0.540113, "min": 0.540113}, "location": {"width": 139, "top": 1021, "height": 42, "left": 862}, "words": " QLNBIHLS"}, {"probability": {"variance": 0.009499, "average": 0.976349, "min": 0.398011}, "location": {"width": 791, "top": 1049, "height": 42, "left": 234}, "words": "入选时年龄超过80岁的患者,将SOTI和 TROPOS资料集中分析的结果显示,本治疗3年"}, {"probability": {"variance": 0.002438, "average": 0.983526, "min": 0.735232}, "location": {"width": 606, "top": 1093, "height": 37, "left": 197}, "words": "后降低了新发生椎体骨折的相对危险性达32%(雷奈酸锶组的发生率19"}, {"probability": {"variance": 0.000387, "average": 0.990898, "min": 0.942801}, "location": {"width": 136, "top": 1108, "height": 24, "left": 886}, "words": "安慰剂组的发生"}, {"probability": {"variance": 0.009129, "average": 0.955603, "min": 0.721748}, "location": {"width": 87, "top": 1138, "height": 25, "left": 195}, "words": "率26.5%)"}, {"probability": {"variance": 0.006088, "average": 0.976533, "min": 0.51595}, "location": {"width": 788, "top": 1184, "height": 41, "left": 234}, "words": "在一项来自合并的SOTI和 TROPOS研究患者的后验分析中,对于治疗前腰椎和/或股骨颈"}, {"probability": {"variance": 0.000174, "average": 0.992902, "min": 0.948954}, "location": {"width": 811, "top": 1228, "height": 43, "left": 195}, "words": "BMD属于骨质疏松症的范围,未发生过骨折但存在至少一种其他的骨折危险因素的患者(N=176"}, {"probability": {"variance": 0.001843, "average": 0.985332, "min": 0.770769}, "location": {"width": 828, "top": 1273, "height": 45, "left": 193}, "words": "本品治疗3年后降低这些患者发生第1次椎体骨折的危险性达72%(椎体骨折的发生率,雷奈酸锶"}, {"probability": {"variance": 0.004377, "average": 0.960039, "min": 0.783782}, "location": {"width": 216, "top": 1322, "height": 26, "left": 192}, "words": "36%vs.安慰剂12.0%"}, {"probability": {"variance": 0.001247, "average": 0.990033, "min": 0.781254}, "location": {"width": 777, "top": 1366, "height": 42, "left": 241}, "words": " ROPOS研究中的亚组患者,需要特别的医疗照顾并且存在骨折的高危险性〔定义为,股骨"}, {"probability": {"variance": 0.00778, "average": 0.963817, "min": 0.579765}, "location": {"width": 823, "top": 1410, "height": 44, "left": 189}, "words": "颈BMD≤-3SD(生产厂商的范围,采用 NHANES III方法相当于-2.4SD)以及年龄≥74岁(n=1977"}, {"probability": {"variance": 0.003369, "average": 0.985869, "min": 0.626478}, "location": {"width": 827, "top": 1455, "height": 45, "left": 190}, "words": "即40%的 TROPOS研究人群)。在这个人群中,与安慰剂相比,经过本品的3年治疗,髋部骨折"}, {"probability": {"variance": 0.001362, "average": 0.988874, "min": 0.846077}, "location": {"width": 295, "top": 1501, "height": 34, "left": 188}, "words": "的危险性降低了36%(详见表2)"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 43, "top": 1583, "height": 18, "left": 317}, "words": " 29-1d"}], "language": 3}